In a murine model of LN, renal ILC3s were the dominant source of IL-22 and were increased in abundance, while IL-22 deficiency ameliorated disease, supporting a pathogenic role for ILC3s in LN, yet whether an analogous mechanism applies to humans is unknown (300). This evidence concerns the gene IL22 and lobular neoplasia.